Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-12-009248
Filing Date
2012-09-07
Accepted
2012-09-07 16:50:02
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tti_10qa-063012.htm 10-Q/A 46950
  Complete submission text file 0001437749-12-009248.txt   8567119

Data Files

Seq Description Document Type Size
2 tlon-20120630.xml EX-101.INS 1955865
3 tlon-20120630.xsd EX-101.SCH 72472
4 tlon-20120630_cal.xml EX-101.CAL 31689
5 tlon-20120630_def.xml EX-101.DEF 346495
6 tlon-20120630_lab.xml EX-101.LAB 432247
7 tlon-20120630_pre.xml EX-101.PRE 350826
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-32626 | Film No.: 121080648
SIC: 2834 Pharmaceutical Preparations